Clinical Trials Browser

OTHER_GOV × pembrolizumab × Dermatologic × Clear all

NCT07349303 2026-01-21

NEOPRIME

Phase 2 Recruiting

Melanoma

NCT05304546 2025-07-22

MK3475-C01

Phase 2 Completed

Melanoma, Neoplasms

NCT02697630 2023-12-08

PEMDAC

Phase 2 Completed

Uveal Melanoma